SOLIGENIX, Inc. (SNGX) intrinsic value & 10-year financials
SOLIGENIX, Inc. (SNGX) has a Graham intrinsic value of $142.42 per share. At $0.35 on Oct 17, 2026, the stock trades 100% below that value.
- Graham intrinsic value
- $142.42
- Share price (Oct 17, 2026)
- $0.35
- Price vs Graham value
- 100% below
- Market cap
- $1.8M
- Revenue (FY2025)
- —
- Revenue growth (10-yr CAGR)
- -42.8%
- ROIC (10-yr avg)
- 169.4%
- Free cash flow (FY2025)
- -$10.3M
SNGX 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | — | -$11.1M | -$2.14 | -$10.3M | — | 371.3% |
| FY2024 | $119.4K | -$8.3M | -$1.66 | — | -7907.7% | 211.6% |
| FY2023 | $839.4K | -$6.1M | -$0.26 | — | -917.1% | 58.6% |
| FY2022 | $948.9K | -$13.8M | -$1.60 | — | -1500.6% | 84.2% |
| FY2021 | $824.3K | -$12.6M | -$0.10 | — | -1594.2% | — |
| FY2020 | $1.9M | -$17.7M | -$0.21 | — | -962.8% | 121.5% |
| FY2019 | $3.2M | -$9.4M | — | — | -327.8% | — |
| FY2018 | $4.0M | -$8.9M | — | — | -228.4% | — |
| FY2017 | $4.7M | -$7.1M | -$0.39 | — | -159.9% | — |
| FY2016 | $10.4M | -$3.2M | -$0.45 | — | -54.6% | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
SOLIGENIX, INC. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
SOLIGENIX, INC. has earned high returns on invested capital, averaging 54.0% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
Over the decade, SOLIGENIX, INC. shows that management has aggressively returned capital to shareholders by retiring 51.7% of outstanding shares.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, SOLIGENIX, INC. is modeled at -42.8% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $142.42 per share.